Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-12

Clinical Trial Update: Lifestyle MIND- Feasibility of Wait-list Control [NA]

View source ↗

Summary

A feasibility trial of a Lifestyle MIND intervention for individuals with Type 2 diabetes mellitus and serious mental illness (including schizophrenia, major de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes Mellitus, Serious Mental Illness | NA | Status: WITHDRAWN